0001209191-23-013215.txt : 20230227
0001209191-23-013215.hdr.sgml : 20230227
20230227165118
ACCESSION NUMBER: 0001209191-23-013215
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230227
DATE AS OF CHANGE: 20230227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fitzgerald Kevin Joseph
CENTRAL INDEX KEY: 0001886431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 23676026
MAIL ADDRESS:
STREET 1: C/O OVID THERAPEUTICS INC.
STREET 2: 1460 BROADWAY, SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-23
0
0001636651
Ovid Therapeutics Inc.
OVID
0001886431
Fitzgerald Kevin Joseph
C/O OVID THERAPEUTICS INC.
441 NINTH AVENUE
NEW YORK
NY
10001
1
0
0
0
Stock Option (Right to Buy)
2.50
2023-02-23
4
A
0
15000
0.00
A
2033-02-22
Common Stock
15000
15000
D
The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date.
/s/ Danielle Mann for Kevin Fitzgerald by PoA
2023-02-27